Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3129 USD | -5.47% |
|
+7.19% | -96.07% |
Jul. 01 | Aptevo Therapeutics Inc. announced that it has received $2.75 million in funding | CI |
Jun. 28 | Aptevo Shares Decline After Pricing of $2.8 Million Stock Offering | MT |
Chart calendar Aptevo Therapeutics Inc.
Upcoming events on Aptevo Therapeutics Inc.
Past events on Aptevo Therapeutics Inc.
2024-06-07 01:00 pm | Annual General Meeting |
2024-06-02 | BIO International Convention |
2024-05-08 08:05 am | Q1 2024 Earnings Release |
2024-03-18 05:30 pm | ROTH Conference |
2024-03-05 08:05 am | Q4 2023 Earnings Release |
2024-02-05 01:00 pm | Extraordinary Shareholders Meeting |
2023-11-14 08:05 am | Q3 2023 Earnings Release |
2023-11-07 08:15 am | Bio-Europe Conference |
2023-08-10 08:05 am | Q2 2023 Earnings Release |
2023-06-02 01:00 pm | Annual General Meeting |
2023-05-11 08:05 am | Q1 2023 Earnings Release |
2023-03-30 07:45 am | Q4 2022 Earnings Release |
2022-12-11 | American Society of Hematology Meeting - Poster No. APVO436 |
2022-11-10 08:05 am | Q3 2022 Earnings Release |
2022-08-11 08:05 am | Interim 2022 Earnings Release |
2022-06-07 01:00 pm | Annual General Meeting |
2022-05-12 08:05 am | Q1 2022 Earnings Release |
2022-04-11 | American Association of Cancer Research Meeting - Poster No : APVO442 |
2022-03-24 08:05 am | FY 2021 Earnings Release |
2021-11-12 08:05 am | Q3 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 32,4 33,1 -2.15% | 4,31 3,68 17.07% | 12,3 12,0 2.2% | 3,11 3,11 0% | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -42,6 -46,1 7.55% | -27,5 -27,2 -1.21% | -21,4 -22,5 4.93% | -28,6 -29,0 1.08% | -28,9 -29,2 1.18% | -28,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -44,7 -47,0 4.83% | -30,9 -25,9 -19.42% | -29,4 -28,8 -1.96% | 7,01 4,36 60.78% | -18,7 -18,0 -3.8% | -28,0 |
Net income Million USD | Released Forecast Spread | -40,4 -45,2 10.54% | -17,8 -16,8 -5.96% | -28,5 -28,8 1.33% | 8,03 4,71 70.48% | -17,4 -18,2 4.27% | -28,0 |
EPS USD | Released Forecast Spread | -610 -698 12.65% | -230 -201 -14.57% | -267 -270 1.14% | 69,1 40,9 68.82% | -62,5 -75,5 17.2% | -8,86 |
Announcement Date | 25/03/20 | 31/03/21 | 24/03/22 | 30/03/23 | 05/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3,11 3,75 -16.96% | 0,00 3,43 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -5,61 -4,57 -22.83% | -7,56 -5,88 -28.67% | -7,78 -7,59 -2.58% | -7,68 -8,00 3.93% | -7,76 -7,97 2.73% | -8,18 -8,00 -2.23% | -6,56 -8,91 26.4% | -6,38 -6,73 5.13% | -6,98 -6,42 -8.85% | -7,02 | -7,05 | -7,09 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,88 -6,26 -25.89% | 27,9 -5,53 603.91% | -7,81 -8,50 8.13% | -5,16 -8,06 35.95% | 1,83 -7,92 123.06% | -7,95 -8,00 0.65% | -6,33 -8,48 25.29% | -6,20 -6,46 4.06% | -6,83 -6,42 -6.53% | -7,02 | -7,05 | -7,09 |
Net income Million USD | Released Forecast Spread | -7,70 -6,26 -23.04% | 28,0 -5,53 606.6% | -7,64 -8,35 8.46% | -4,64 -7,96 41.69% | 2,77 -7,82 135.44% | -7,95 -8,00 0.65% | -6,33 -8,86 28.54% | -5,90 -6,68 11.62% | -6,83 -6,42 -6.53% | -7,02 | -7,05 | -7,09 |
EPS USD | Released Forecast Spread | -68,2 -40,9 -66.67% | 246 -48,8 602.7% | -66,0 -72,2 8.54% | -41,8 -67,3 37.91% | 17,2 -52,1 132.91% | -54,1 -49,3 -9.82% | -22,0 -33,0 33.33% | -6,16 -18,0 65.85% | -9,95 -12,8 22.54% | -1,93 | -1,71 | -1,70 |
Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 05/03/24 | 08/05/24 | - | - | - |
Past sector events for Aptevo Therapeutics Inc.
2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APVO Stock
- Calendar Aptevo Therapeutics Inc.